Maxwellia attracts investment for OTC switching

4 April 2018 - Deborah Wilkes

Archived

Maxwellia has raised early-stage investment worth GBP0.70 million (USD0.98 million) to fund its ambitious programme of switching medicines from prescription-to-OTC status

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: